Clinical Trial

Impact of P53 and SIRT1 in Type 2 Diabetes

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
Trial Details
NCT Number NCT03925714
Lead Sponsor Sherief Abd-Elsalam
Conditions DM
Enrollment 90 participants
Start Date 2019-04-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2019-04-24